Article
EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer.
Histology and histopathology - 1 Apr 2014
Martin Vittoria, Zanellato Elena, Franzetti-Pellanda Alessandra, Molinari Francesca, Movilia Alessandra, Paganotti Alessia, Deantonio Letizia, De Dosso Sara, Assi Agnese, Crippa Stefano, Boldorini Renzo, Mazzucchelli Luca, Saletti Piercarlo, Frattini Milo
Abstract excerpt
BACKGROUND: Combined chemoradiation therapy is the gold standard in the treatment of squamous cell anal cancer (SCAC). However, even if the response rate is very high, many patients eventually relapse or experience a reccurrence, thus requiring an invasive surgical procedure that has severe side effects. Most SCAC tumors overexpress epidermal growth factor receptor (EGFR); therefore, it is reasonable to consider...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
